The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Price, N. M.
Right arrow Articles by Friedland, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Price, N. M.
Right arrow Articles by Friedland, J. S.
The Journal of Immunology, 2001, 166: 4223-4230.
Copyright © 2001 by The American Association of Immunologists

Identification of a Matrix-Degrading Phenotype in Human Tuberculosis In Vitro and In Vivo1

Nicholas M. Price*, Jeremy Farrar{dagger},{ddagger}, Tran Thi Hong Chau§, Nguyen Thi Hoang Mai§, Tran Tinh Hien§ and Jon S. Friedland2,*

* Department of Infectious Diseases, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom; {dagger} Wellcome Trust Clinical Research Unit, Ho Chi Minh City, Viet Nam; {ddagger} Center for Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom; and § Center for Tropical Diseases, Ho Chi Minh City, Viet Nam.

Tuberculous meningitis is characterized by cerebral tissue destruction. Monocytes, pivotal in immune responses to Mycobacterium tuberculosis, secrete matrix metalloproteinase-9 (MMP-9), which facilitates leukocyte migration across the blood-brain barrier, but may cause cerebral injury. In vitro, human monocytic (THP-1) cells infected by live, virulent M. tuberculosis secreted MMP-9 in a dose-dependent manner. At 24 h, MMP-9 concentrations increased 10-fold to 239 ± 75 ng/ml (p = 0.001 vs controls). MMP-9 mRNA became detectable at 24–48 h. In contrast, tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) gene expression and secretion were similar to constitutive levels from controls at 24 h and increased just 5-fold by 48 h. In vivo investigation revealed MMP-9 concentration per leukocyte in cerebrospinal fluid (CSF) from tuberculous meningitis patients (n = 23; median (range), 3.19 (0.19–31.00) ng/ml/cell) to be higher than that in bacterial (n = 12; 0.23 (0.01–18.37) ng/ml/cell) or viral meningitis (n = 20; 0.20 (0.04–31.00) ng/ml/cell; p < 0.01). TIMP-1, which was constitutively secreted into CSF, was not elevated in tuberculous compared with bacterial meningitis or controls. Thus, a phenotype in which MMP-9 activity is relatively unrestricted by TIMP-1 developed both in vitro and in vivo. This is functionally significant, since MMP-9 concentrations per CSF leukocyte (but not TIMP-1 concentrations) were elevated in fatal tuberculous meningitis and in patients with signs of cerebral tissue damage (unconsciousness, confusion, or neurological deficit; p < 0.05). However, MMP-9 activity was unrelated to the severity of systemic illness. In summary, M. tuberculosis-infected monocytic cells develop a matrix-degrading phenotype, which was observed in vivo and relates to clinical signs reflecting cerebral injury in tuberculous meningitis.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. T. Elkington, J. A. Green, J. E. Emerson, L. D. Lopez-Pascua, J. J. Boyle, C. M. O'Kane, and J. S. Friedland
Synergistic Up-Regulation of Epithelial Cell Matrix Metalloproteinase-9 Secretion in Tuberculosis
Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. E. Harris, J. A. Green, P. T. Elkington, and J. S. Friedland
Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion
J. Leukoc. Biol., February 1, 2007; 81(2): 548 - 556.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. E. Harris, M. Fernandez-Vilaseca, P. T. G. Elkington, D. E. Horncastle, M. B. Graeber, and J. S. Friedland
IFN{gamma} synergizes with IL-1{beta} to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis
FASEB J, February 1, 2007; 21(2): 356 - 365.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Harris, R. K. Nuttall, P. T. Elkington, J. A. Green, D. E. Horncastle, M. B. Graeber, D. R. Edwards, and J. S. Friedland
Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo
J. Immunol., January 15, 2007; 178(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. L. Taylor, J. M. Hattle, S. A. Dreitz, J. M. Troudt, L. S. Izzo, R. J. Basaraba, I. M. Orme, L. M. Matrisian, and A. A. Izzo
Role for Matrix Metalloproteinase 9 in Granuloma Formation during Pulmonary Mycobacterium tuberculosis Infection
Infect. Immun., November 1, 2006; 74(11): 6135 - 6144.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P T G Elkington and J S Friedland
Matrix metalloproteinases in destructive pulmonary pathology
Thorax, March 1, 2006; 61(3): 259 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. P. Simmons, G. E. Thwaites, N. T. H. Quyen, E. Torok, D. M. Hoang, T. T. H. Chau, P. P. Mai, N. T. N. Lan, N. H. Dung, H. T. Quy, et al.
Pretreatment Intracerebral and Peripheral Blood Immune Responses in Vietnamese Adults with Tuberculous Meningitis: Diagnostic Value and Relationship to Disease Severity and Outcome
J. Immunol., February 1, 2006; 176(3): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. T. G. Elkington, R. K. Nuttall, J. J. Boyle, C. M. O'Kane, D. E. Horncastle, D. R. Edwards, and J. S. Friedland
Mycobacterium tuberculosis, but Not Vaccine BCG, Specifically Upregulates Matrix Metalloproteinase-1
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1596 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Elass, L. Aubry, M. Masson, A. Denys, Y. Guerardel, E. Maes, D. Legrand, J. Mazurier, and L. Kremer
Mycobacterial Lipomannan Induces Matrix Metalloproteinase-9 Expression in Human Macrophagic Cells through a Toll-Like Receptor 1 (TLR1)/TLR2- and CD14-Dependent Mechanism
Infect. Immun., October 1, 2005; 73(10): 7064 - 7068.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Liu, T. Desta, H. He, and D. T. Graves
Diabetes Alters the Response to Bacteria by Enhancing Fibroblast Apoptosis
Endocrinology, June 1, 2004; 145(6): 2997 - 3003.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. M. Wright and J. S. Friedland
Regulation of monocyte chemokine and MMP-9 secretion by proinflammatory cytokines in tuberculous osteomyelitis
J. Leukoc. Biol., June 1, 2004; 75(6): 1086 - 1092.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. M. Price, R. H. Gilman, J. Uddin, S. Recavarren, and J. S. Friedland
Unopposed Matrix Metalloproteinase-9 Expression in Human Tuberculous Granuloma and the Role of TNF-{alpha}-Dependent Monocyte Networks
J. Immunol., November 15, 2003; 171(10): 5579 - 5586.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. Selman, J. Cisneros-Lira, M. Gaxiola, R. Ramirez, E. M. Kudlacz, P. G. Mitchell, and A. Pardo
Matrix Metalloproteinases Inhibition Attenuates Tobacco Smoke-Induced Emphysema in Guinea Pigs
Chest, May 1, 2003; 123(5): 1633 - 1641.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.